Effects of EdU labeling on mesenchymal stem cells
- 1 January 2013
- journal article
- Published by Elsevier in Cytotherapy
- Vol. 15 (1) , 57-63
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (DK64538, DK045370, DK069655)
This publication has 21 references indexed in Scilit:
- Adipose Tissue-Derived Stem Cells Secrete CXCL5 Cytokine with Neurotrophic Effects on Cavernous Nerve RegenerationThe Journal of Sexual Medicine, 2011
- Adipose derived stem cells: efficiency, toxicity, stability of BrdU labeling and effects on self-renewal and adipose differentiationMolecular and Cellular Biochemistry, 2011
- Adipose tissue-derived stem cells secrete CXCL5 cytokine with chemoattractant and angiogenic propertiesBiochemical and Biophysical Research Communications, 2010
- Injections of Adipose Tissue-Derived Stem Cells and Stem Cell Lysate Improve Recovery of Erectile Function in a Rat Model of Cavernous Nerve InjuryThe Journal of Sexual Medicine, 2010
- The Effect of Intracavernous Injection of Adipose Tissue-Derived Stem Cells on Hyperlipidemia-Associated Erectile Dysfunction in a Rat ModelThe Journal of Sexual Medicine, 2010
- Treatment of stress urinary incontinence with adipose tissue-derived stem cellsCytotherapy, 2010
- Mesenchymal Stromal Cells: Current Understanding and Clinical StatusStem Cells, 2009
- Labeling and tracking of mesenchymal stromal cells with EdUCytotherapy, 2009
- Insulin growth factor signaling mediates neuron-like differentiation of adipose tissue-derived stem cellsDifferentiation, 2008
- A chemical method for fast and sensitive detection of DNA synthesis in vivoProceedings of the National Academy of Sciences, 2008